Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluating the Breast Cancer Quality of Care Indicators in Iran; Multicenter Study Publisher Pubmed



Rajabpour MV1, 2 ; Seyyedsalehi MS1 ; Nahvijou A1 ; Nemati S1 ; Javanmard SH3 ; Manteghinejad A4 ; Abdi S1 ; Farazmand B1 ; Pirnejad H5 ; Sorkheh AG6 ; Anasari J7 ; Bahrami M8 ; Marzban M9 ; Ghoreishi SM9 Show All Authors
Authors
  1. Rajabpour MV1, 2
  2. Seyyedsalehi MS1
  3. Nahvijou A1
  4. Nemati S1
  5. Javanmard SH3
  6. Manteghinejad A4
  7. Abdi S1
  8. Farazmand B1
  9. Pirnejad H5
  10. Sorkheh AG6
  11. Anasari J7
  12. Bahrami M8
  13. Marzban M9
  14. Ghoreishi SM9
  15. Nia YBI10
  16. Bakhshi F11
  17. Ansarimoghaddam A12
  18. Binabaj MM13
  19. Nourmohammadi H14
  20. Omranipour R15
  21. Abdollahi A16
  22. Aghili M2, 17
  23. Mohagheghi MA1
  24. Ghanbarimotlagh A18
  25. Basu P19
  26. Boffetta P20, 21
  27. Zendehdel K1, 22
Show Affiliations
Authors Affiliations
  1. 1. Cancer Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Metabolomics and Genomics Research Center, Endocrinology and Metabolism Research Institute, Cellular and Molecular Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Cancer Prevention Research Center, Omid Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran
  6. 6. Department of Surgery, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
  7. 7. Arak University of Medical Sciences, Arak, Iran
  8. 8. Clinical Research Development Center, The Persian Gulf Martyrs, Bushehr University of Medical Science, Bushehr, Iran
  9. 9. Cellular and Molecular Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  10. 10. Department of Internal Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
  11. 11. Social Determinants of Health Research Center, School of Health, Gilan University of Medical Sciences, Rasht, Iran
  12. 12. Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
  13. 13. Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
  14. 14. Department of Internal Medicine Shahid, Mostafa Khomeini Hospital, Ilam, Iran
  15. 15. Breast Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  16. 16. Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  17. 17. Radiotherapy Research Centre, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  18. 18. Department of Radiotherapy, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  19. 19. International Agency for Research On Cancer, Lyone, France
  20. 20. Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, United States
  21. 21. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
  22. 22. Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: BMC Cancer Published:2025


Abstract

Background: Data on quality-of-care indicators for breast cancer patients is limited in low—and middle-income countries. We evaluated the indicators in Iran. Method: A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran. Result: In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels. Conclusion: The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low—and middle-income countries. © The Author(s) 2025.